Marimekko Corporation: Managers' transactions (Alahuhta-Kasko)

Marimekko Corporation, Managers’ transactions, 7 July 2026 at 4.30 p.m. EEST

Marimekko Corporation: Managers' transactions (Alahuhta-Kasko)

Based on an authorization given by Marimekko’s AGM on 16 April 2026, the Board of Directors of Marimekko decided to transfer free of charge Marimekko shares held by the company to the members of Marimekko Management Group in accordance with the terms of the Performance share plan 2022–2026. Pursuant to the resolution, shares have been transferred as follows:

____________________________________________

Person subject to the notification requirement
Name: Alahuhta-Kasko, Tiina
Position: Chief Executive Officer
Issuer: Marimekko Corporation
LEI: 74370053IOY42B9YJ350

Notification type: INITIAL NOTIFICATION
Reference number: 74370053IOY42B9YJ350_20260706122839_64
____________________________________________

Transaction date: 2026-07-06
Venue not applicable
Instrument type: SHARE
ISIN: FI0009007660
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 22023 Unit price: 0.00 EUR

Aggregated transactions
(1): Volume: 22023 Volume weighted average price: 0.00 EUR

MARIMEKKO CORPORATION 

Released by:  
Corporate Communications, Leena Salomaa, tel. +358 9 758 7233

DISTRIBUTION: 
Nasdaq Helsinki Ltd 
Key media 

Marimekko is a Finnish lifestyle design company renowned for its original prints and colors. The company’s product portfolio includes high-quality clothing, bags and accessories as well as home décor items ranging from textiles to tableware. When Marimekko was founded in 1951, its unparalleled printed fabrics gave it a strong and unique identity. In 2025, the company's net sales totaled EUR 190 million and comparable operating profit margin was 17.1 percent. Globally, there are over 170 Marimekko stores, and online store serves customers in 39 countries. The key markets are Northern Europe, the Asia-Pacific region and North America. The Group employs about 490 people. The company’s share is quoted on Nasdaq Helsinki Ltd. www.marimekko.com  

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• Norton Manx R Earns Landmark International Design Excellence Award for Reimagining the Superbike
• Small Essential, Big Difference: How Modofo Makes Everyday Drinkware More Stylish